Survival curves for four model genes (ABCC3, EMP3, AL161787.1, and IGFBP2) highlighted IGFBP2 as a significant marker of decreased survival outcomes in glioma patients (Figure 7A). This evidence concerns the gene ABCC3 and central nervous system cancer.